Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease

Psychiatry Research - Neuroimaging

Volumn 155, Issue 2, 2007, Pages 147-154

  Hunt, Aoife ^a   Schönknecht, Peter ^a   Henze, Marcus ^a   Seidl, Ulrich ^a   Haberkorn, Uwe ^a   Schröder, Johannes ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

AACD; AD; Aging associated cognitive decline; Conversion; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; TEMPORAL CORTEX;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; FRONTAL LOBE; FUNCTIONAL LATERALITY; GLUCOSE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; POSITRON-EMISSION TOMOGRAPHY; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE; TISSUE DISTRIBUTION;

EID: 34249896677     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2006.12.003     Document Type: Article

References (40)

1. Arnaiz E., Jelic V., Almkist O., Wahlund L.-O., Winblad B., Valind S., and Nordberg A. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. NeuroReport 12 (2001) 851-855
2. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica 82 (1991) 239-259
3. Buchsbaum M., Kesslak J.P., Lynch G., Chui H., Wu J., Sicott N., Hazlett E., Teng E., and Cotman C.W. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies. Archives of General Psychiatry 48 (1991) 840-847
4. Chételat G., Desgranges B., de la Sayette M.D., Viader M.D., Eustache F., and Baron J.-C. Mild cognitive impairment. Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology 60 (2003) 1374-1377
5. De Leon M.J., Convit A., Wolf O.T., Tarshish C.Y., DeSanti S., Rusinek H., Tsui W., Kandil E., Scherer A.J., Roche A., Imossi A., Bobinski M., Caraos C., Lesbro P., Schlyer D., Poirer P., Reisberg B., and Fowler J. Prediction of cognitive decline in normal elderly subjects with 2-(18F)-fluoro-2-deoxy-d-glucose/positron-emission-tomography (FDG/PET). Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 10966-10971
6. De Santi S., de Leon M., Rusinek H., Convit A., Tarshish A., Tsui W.H., Kandil E., Boppana M., Daisley K., Wang G.J., Schlyer D., and Fowler J. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiology of Aging 22 (2001) 529-539
7. Drzezga A., Lautenschlager N., Siebner H., Riemenschneider M., Willoch F., Minoshima S., Schwaiger M., and Kurz A. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. European Journal of Nuclear Medicine and Molecular Imaging 30 (2003) 1104-1113
8. Elias M.F., Beiser A., Wolf P.A., Au R., White R.F., and D'Agostino R.B. The preclinical phase of Alzheimer disease. A 22-year prospective study of the Framingham cohort. Archives of Neurology 57 (2000) 808-813
9. Encinas M., De Juan R., Marcos A., Gil P., Barabash A., Fernandez C., De Ugarte C., and Cabranes J.A. Regional blood flow assessed with 99mTc_ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 30 (2003) 1473-1480
10. Folstein M.F., Folstein S.E., and MsHugh P.R. 'Mini mental state'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12 (1975) 189-198
11. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C.D., and Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 2 (1995) 189-210
12. Hachinski V.L., Iliff D., Zihka E., Du Boulay G.H., McAllister V.L., Marshall J., Russell R.W., and Symon L. Cerebral blood flow in dementia. Archives of Neurology 32 (1975) 632-637
13. Haxby J.V., Duara R., Grady C.L., Cutler N.R., and Rapoport S.I. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism 5 (1985) 193-200
14. Herholz K., Salmon E., Perani D., Baron J.C., Holthoff V., Frölich L., Schonknecht P., Ito K., Mielke R., Kalbe E., Zuendorf G., Belbeuck X., Pelati O., Anchisi D., Fazio F., Kerrouche N., Desgranges B., Eustache F., Beuthien-Baumann B., Menzel C., Schroder J., Kato T., Arahata Y., Henze M., and Heiss W.-D. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage 17 (2002) 302-316
15. Hsiung G.Y., Sadovnick A.D., and Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 171 (2004) 863-867
16. Huang C., Wahlund L.O., Svensson L., Winblad B., and Julin P. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC (Biomedcentral) Neurology 2 (2002) 9
17. Ishiwata A., Kitamura S., Nagazumi A., and Terashi A. Cerebral blood flow of patients with age-associated memory impairment and the early stage of Alzheimer's disease. A study by SPECT using the ARG method. Nippon Ika Daigaku Zasshi 65 (1998) 140-147
18. Johnson K.A., Jones K., Holman B.L., Becker J.A., Spiers P.A., Satlin A., and Albert M.S. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50 (1998) 1563-1571
19. Levy R. Aging-associated cognitive decline. International Psychogeriatrics 6 (1994) 63-68
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-965
21. Morris J.C. The Clinical Dementia Rating. Current version and scoring rules. Neurology 43 (1993) 2412-2414
22. Nestor P.J., Fryer T.D., Ikeda M., and Hodges J.R. Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease). European Journal of Neuroscience 18 (2003) 2663-2667
23. Nestor P.J., Scheltens P., and Hodges J.R. Advances in the early detection of Alzheimer's disease. Nature Medicine 10 (2004) S34-S41
24. Okamura N., Shinkawa M., Arai H., Matsui T., Nakajo K., Maruyama M., Hu X.S., and Sasaki H. Prediction of progression in patients with mild cognitive impairment using IMP-SPECT. Nippon Ronen Igakkai Zasshi 37 (2000) 974-978
25. Pantel J., Schönknecht P., Essig M., Amann M., Eysenbach K., Schad L.R., and Schröder J. Progressive medial temporal lobe changes in Alzheimer's disease revealed by quantitative MRI: potential use for monitoring of drug-related changes. Drug Development Research 56 (2002) 51-56
26. Pantel J., Kratz B., Essig M., and Schröder J. Parahippocampal volume deficits in subjects with aging-associated cognitive decline. American Journal of Psychiatry 160 (2003) 379-382
27. Pantel J., Schönknecht P., Essig M., and Schröder J. Distribution of cerebral atrophy as assessed by magnetic resonance imaging reflects patterns of neuropsychological deficits in Alzheimer's dementia. Neuroscience Letters 361 (2004) 17-20
28. Petersen P.C., and Morris J.C. In: Petersen P.C. (Ed). Clinical Features (of MCI) in Mild Cognitive Impairment, Aging to Alzheimer's Disease (2003), University Press, New York
29. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Pantieri G., and Mariani E. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dementia and Geriatric Cognitive Disorders 21 (2006) 51-58
30. Ritchie K., Arteron S., and Touchon J. Classification criteria for mild cognitive impairment - a population-based validation study. Neurology 56 (2001) 37-42
31. Scarmeas N., and Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Current Neurology and Neuroscience Reports 4 (2004) 374-380
32. Schönknecht P., Pantel J., Hartmann T., Werle E., Volkmann M., Essig M., Amann M., Zanabili N., Bardenheuer H., Hunt A., and Schröder J. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatry Research: Neuroimaging 120 (2003) 231-238
33. Schönknecht P., Pantel J., Kruse A., and Schröder J. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. American Journal of Psychiatry 162 (2005) 2071-2077
34. Schröder J., Kratz B., Pantel J., Minnemann E., Lehr U., and Sauer H. Prevalence of mild cognitive impairment in a community sample. Journal of Neural Transmission Supplement 54 (1998) 51-59
35. Schröder J., Buchsbaum M.S., Shihabuddin L., Tang C., Wei T., Spiegel-Cohen J., Hazlett E.A., Abel L., Luu-Hsia C., Ciaravolo T.M., Marin D., and Davis K.L. Patterns of cortical activity and memory performance in Alzheimer's disease. Biological Psychiatry 49 (2001) 426-436
36. Silverman D.H., Small G.W., Chang C.Y., Lu C.S., Kung De Aburto M.A., Chen W., Czernin J., Rapoport S.I., Pietrini P., Alexander G.E., Shapiro M.B., Jagust W.J., Heffmann J.M., Welsh-Bohmer K.A., Alauri A., Clark C.M., Salmon E., de Leon M.J., Mielke R., Cummings J.L., Kowell A.P., Gambhir S.S., Hoh C.U., and Phelps M.E. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. Journal of the American Medical Association 286 (2001) 2110-2117
37. Staffen W., Schonauer U., Zauner H., Spindler I., Mair A., Iglseder B., Bernroider G., and Ladurner G. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation. Journal of Neural Transmission 286 (2005) 2110-2117
38. Talairach J.A., and Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain (1988), Thieme, Paris
39. Tanaka M., Fukuyama H., Yamauchi H., Narita M., Nabatame H., Yokode M., Fujimoto N., Kita T., and Murakami M. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. Journal of Neuroimaging 12 (2002) 112-118
40. Winblad W., Palmer K., Kivipelto M., Jelic V., and Fratiglioni L. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 256 (2004) 240-246